Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $949.59 MXN
Change Today 0.00 / 0.00%
Volume 0.0
MRK* On Other Exchanges
Symbol
Exchange
New York
Mexico
EN Paris
Sao Paulo
Frankfurt
As of 4:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Adam H. Schechter

President of Global Human Health and Executive Vice President, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 2 different industries.

See Board Relationships
50$10,327,336
As of Fiscal Year 2014

Background*

Mr. Adam H. Schechter has been the President of Global Human Health and Executive Vice President at Merck & Co., Inc. since May 2010. Mr. Schechter served as President of Global Pharmaceuticals at Merck Frosst Canada Ltd., a subsidiary of Merck & Co. Inc. He served as the President of Global Pharmaceuticals of Merck & Co. Inc. since August 2007. He served as President of U.S. Human Health - commercial of Merck & Co. Inc. from July 2006 to August 2007. Mr. Schechter served ...

Read Full Background

Corporate Headquarters*

2000 Galloping Hill Road
Kenilworth, New Jersey 07033

United States

Phone: 908-740-4000
Fax: --

Board Members Memberships*

2013-Present
Director, Member of Compensation Committee and Member of Quality & Compliance Committee

Education*

BA 1986
La Salle University

Other Affiliations*

Annual Compensation*

Salary$962,388
Total Annual Compensation$962,388

Stock Options*

Restricted Stock Awards$4,623,673
All Other Compensation$103,994
Exercised Options18,000
Exercised Options Value$143,230
Exercisable Options717,570
Exercisable Options Value$12,794,476
Unexercisable Options464,883
Unexercisable Options Value$3,548,105
Total Value of Options$16,485,810
Total Number of Options1,200,453

Total Compensation*

Total Annual Cash Compensation$2,499,316
Total Short Term Compensation$962,388
Other Long Term Compensation$4,727,667
Total Calculated Compensation$10,327,336
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK*:MM $949.59 MXN 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€3.2M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.4M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.